LONDON — European stocks are expected to open flat to higher on Tuesday as global markets await the U.S. Federal Reserve’s interest rate decision. The U.K.’s FTSE index is seen opening a touch higher, Germany’s DAX and France’s CAC 40 0.2% lower and Italy’s FTSE MIB just below the flatline, according to data from IG. The…
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday ‘s key moments. 1. Stocks moved higher Monday, with all three indexes again touching fresh record intra-day highs due to easing trade tensions between the United States and China. But for Jim…
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023. Bloomberg | Bloomberg | Getty Images Swiss pharmaceutical giant Novartis is nearing a deal to buy biotechnology company Avidity Biosciences for more than $70 a share, Bloomberg News reported, citing a person familiar with the…
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Drugmakers are increasingly using telehealth platforms to sell their medicines directly to patients…
Rafael Henrique | Lightrocket | Getty Images Britain’s GSK on Wednesday became the latest pharmaceutical firm to commit bumper investment into the U.S., as President Donald Trump is in the U.K. for a three-day state visit. The drug maker committed to investing at least $30 billion in U.S. research and developing (R&D) and manufacturing over…
A variety of generic pills and capsules. Nenov | Moment | Getty Images Pharmaceutical firms are scrambling to respond to a fresh ultimatum from U.S. President Donald Trump demanding “binding commitments” to lower their drug prices stateside. The White House said Thursday that President Trump had sent letters to 17 major pharmaceutical firms outlining the…
Shelf of pharmaceutical products. D3sign | Moment | Getty Images The pharmaceutical industry is scrambling with scenario planning as U.S. President Donald Trump’s 200% tariff proposal threatens to drive up drug prices and rip out corporate profit margins. The president once again warned on Tuesday that long-awaited industry-wide tariffs would be announced “very soon” after…
